Sodexo shareholders give green light to Pluxee spin-off
(Reuters) – Sodexo shareholders on Tuesday approved the spin-off of its voucher and benefits division Pluxee, paving the way for its listing on Euronext Paris on Feb. 1. French food…
(Reuters) – Sodexo shareholders on Tuesday approved the spin-off of its voucher and benefits division Pluxee, paving the way for its listing on Euronext Paris on Feb. 1. French food…
MEXICO CITY (Reuters) – Mexico’s Grupo Televisa is set to launch the spin-off of its sports, gaming and some editorial operations in February, to focus in its core business, documents…
By Chris Thomas and Sethuraman N R BENGALURU (Reuters) -Jio Financial Services (JFS) has been valued at around $20 billion after its stock price was set at a much higher-than-expected…
ZURICH (Reuters) – As UBS’s takeover of former rival Swiss bank Credit Suisse nears completion, details are emerging of what the new merged bank will look like. UBS is working…
ZURICH (Reuters) – UBS has hired JPMorgan to explore a possible IPO of Credit Suisse’s domestic business, Zurich based finance blog Inside Paradeplatz reported on Thursday. Last month UBS agreed…
By Giulio Piovaccari MILAN (Reuters) – Maserati aims to increase its margin on operating profit to 15% in the next 12 months and sees a longer term target of 20%…
LONDON (Reuters) – The chief executive of Vale SA said on Friday the Brazilian iron ore miner is reconsidering a near-term spin-off of its base metals business and an eventual…
By Abigail Summerville and Anirban Sen NEW YORK (Reuters) – Kroger Co and Albertsons Cos Inc are willing to divest up to 650 supermarket stores to secure regulatory clearance for…
(Reuters) -Johnson & Johnson named its consumer business Kenvue on Wednesday, moving ahead with its plans to spin-off the unit in what would be the biggest shake-up in the healthcare…
SAO PAULO (Reuters) – Brazil’s Natura & Co Holding SA said on Thursday its board is not considering a spinoff of its Aesop cosmetics brand or the sale of Body…
By Natalie Grover LONDON (Reuters) – Novartis CEO Vas Narasimhan could struggle to woo investors to the listing of generics drugs business Sandoz, as weaker drug prices and jittery financial…
(Reuters) – The abrupt exit of Gap Inc’s chief executive on the back of falling sales and shrinking margins will likely push the struggling apparel retailer to sell one or…
– GlaxoSmithKline said on Tuesday its consumer healthcare venture with Pfizer will be named Haleon, as the British drugmaker confirmed the business will be spun off in mid-2022 as planned…